Nektar Therapeutics · NASDAQ:NKTR
BlackRock, Inc. reported a 7.80% stake in Nektar Therapeutics (Schedule 13G)
Event Jun 30, 2026 · Filed Jul 29, 2026
BlackRock, Inc. reported a 7.80% stake in Nektar Therapeutics, 2,643,796 shares, as a passive investor on Jun 30, 2026. Filed Jul 29, 2026 (Schedule 13G).
- Stake
- 7.80%
- Shares
- 2,643,796
- Intent
- Passive
- What changed
- Crossed above 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| BlackRock, Inc. | 7.80% | 2,643,796 |
Source
Related
- Nektar Therapeutics
- BlackRock, Inc.
- Nektar Therapeutics shareholders
- Schedule 13G/A · BlackRock, Inc. · Jul 18, 2025
- Schedule 13G/A · Two Seas Capital LP · Sep 28, 2026
- Form 4 · Whitfield Roy A · Sep 25, 2026
- Form 4 · Greer R Scott · Sep 25, 2026
- Form 4 · Chess Robert · Sep 25, 2026
- Form 4 · Brainard Diana · Sep 25, 2026